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Editors’ NotesAdding to the Stem Cell Tool Box
Sometimes stem cell research tools come in unusual ‘‘packages.’’ In this issue, two unrelated articles offer distinct resources that
may help move the field toward eventual therapeutic interventions. In one example, Thomas Graf and colleagues describe an
in vitro system that induces lineage reprogramming of B lymphocytes into macrophages that is 100% efficient
and complete in only 2–3 days. By providing a venue with which to ‘‘watch’’ as morphological and gene
expression changes occur during the reprogramming process, the authors provide a resource that could
be tailored to study cell-fate transformation pathways in other settings. Meanwhile, in their Brief Report, Lu
and colleagues describe the creation of an extensive hESC bank in China that not only offers insight into
the derivation process of hESCs from IVF-incompetent embryos but also demonstrates that a relatively small
pool of cell lines is sufficient to provide a matched donor sample for the local patient population, including an
ethnic minority. Their data correlate nicely with mathematical estimates that have been generated by modeling
the theoretical needs for a sufficiently diverse hESC bank and also indicate that otherwise clinically useless
blastocysts may offer a valuable source of rare homozygous, euploid hESC lines.
The Curious Case of TGF-b
The TGF-b signaling cascade has been implicated in regulating a wide range of cell types and relevant fate outcomes. Two studies in
this issue connect the TGF-b pathway to the Sox family of transcription factors, but in distinct ways. Miyazono and colleagues inves-
tigate the influence of the TGF-b pathway on the growth and maintenance of human glioma-initiating cells. They find that by inhibiting
TGF-b, its target Sox4 no longer activates downstream effector Sox2, and the glioma cells differentiate in culture and lose their in vivo
tumor-forming capacity. In contrast, a small-molecule screen conducted by Eggan and coauthors identified a different TGF-b inhib-
itor, called RepSox, that could function in the standard Yamanaka reprogramming cocktail to replace the need for Sox2 or cMyc
in the generation of iPSCs. RepSox treatment correlated with induction of Nanog rather than Sox family transcription factors.
Thus, depending on the context, TGF-b inhibition appears to be able to promote either dedifferentiation into the pluripotent,
self-renewing state or loss of cancer stem cell traits.
Slow and Steady Wins the Race
Two independent studies from the Brunet and DePinho laboratories demonstrate that the neural stem and progenitor cell pools
present in the adult mouse are dependent on the PI3K-AKT-FoxO pathway. As discussed in more detail in the Preview article
from Chen and Finkel, the two groups use distinct approaches to delete one or more FoxO transcription factors from the neural
lineage. In the absence of this arm of the so-called longevity axis, initial proliferation is enhanced and neonatal brain size is
elevated, but subsequent decline of the pool of primitive neural progenitors in the adult suggests that quiescence and long-
term self-renewal are lost in favor of premature differentiation. Analyzing the results of gene expression profiling of FoxO-deficient
neural progenitors may offer insight into important pathways to target in hopes of modulating the effects of aging on stem cell
populations.
Seeking Needles in Haystacks
Although the precise frequency of a stem cell population present in a particular tissue or organ probably varies with location and
physiological condition, it remains challenging in most cases to find markers that reliably label the stem cell pool. Making progress
on this issue with respect to neural progenitors, Benezra and colleagues report in this issue that the transcrip-
tional regulator Id1 reliably marks a pool of subventricular neural stem cells. Using both in vivo and in vitro
analyses, the authors demonstrate that Id genes are expressed by and are required for the function of self-
renewing B1-type astrocytes, which give rise to neuroblasts and downstream olfactory bulb interneurons.
Recent advances have also been made in the identification and localization of adipocyte stem cells, and Graff
and coauthors present a Review of the current state of the field. Their combined historical and forward-looking
perspective highlights the endocrine function of adipose tissue, as well as the extensive and global health
crisis that, at least to some degree, originates from metabolic irregularities that might be modified by manip-
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